Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis S Harris

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Drug and Alcohol Dependence|March 15, 2006
Exempt preparations: Historical perspectivesLouis S Harris
European Journal of Pharmacology|October 21, 2005
Effects of JDTic, a selective kappa-opioid receptor antagonist, on the development and expression of physical dependence on morphine using a rat continuous-infusion modelF Ivy Carroll, Louis S Harris, Mario D Aceto
Pharmacology, Biochemistry, and Behavior|August 8, 2009
Removal of continuous nicotine infusion produces somatic but not behavioral signs of withdrawal in miceAndrew J Kwilasz, Louis S Harris, Robert E Vann
Journal of Medicinal Chemistry|July 22, 2005
Effect of a 6-cyano substituent in 14-oxygenated N-methylmorphinans on opioid receptor binding and antinociceptive potencyMariana Spetea, Elisabeth Greiner, Mario D Aceto, et al.
European Journal of Pharmacology|April 17, 2007
Pharmacological studies with a nonpeptidic, delta-opioid (-)-(1R,5R,9R)-5,9-dimethyl-2'-hydroxy-2-(6-hydroxyhexyl)-6,7-benzomorphan hydrochloride ((-)-NIH 11082)Mario D Aceto, Everette L May, Louis S Harris, et al.
Journal of Medicinal Chemistry|September 5, 2003
Synthesis and biological evaluation of 14-alkoxymorphinans. 20. 14-phenylpropoxymetopon: an extremely powerful analgesicJohannes Schütz, Mariana Spetea, Martin Koch, et al.
Experimental and Clinical Psychopharmacology|August 11, 2004
Discriminative stimulus, reinforcing, physical dependence, and antinociceptive effects of oxycodone in mice, rats, and rhesus monkeysPatrick M Beardsley, Mario D Aceto, Charles D Cook, et al.
European Journal of Pharmacology|April 27, 2007
NIH 11082 produces anti-depressant-like activity in the mouse tail-suspension test through a delta-opioid receptor mechanism of actionPattipati S Naidu, Aron H Lichtman, Carey C Archer, et al.
Bioorganic & Medicinal Chemistry|December 7, 2002
N-(trifluoromethyl)benzyl substituted N-normetazocines and N-norketobemidonesEverette L May, Andrew Coop, James H Woods, et al.
International Journal of Medicinal Chemistry|May 9, 2015
MDAN-21: A Bivalent Opioid Ligand Containing mu-Agonist and Delta-Antagonist Pharmacophores and Its Effects in Rhesus MonkeysMario D Aceto, Louis S Harris, S Stevens Negus, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Drug and Alcohol Dependence|March 15, 2006
Exempt preparations: Historical perspectivesLouis S Harris
European Journal of Pharmacology|October 21, 2005
Effects of JDTic, a selective kappa-opioid receptor antagonist, on the development and expression of physical dependence on morphine using a rat continuous-infusion modelF Ivy Carroll, Louis S Harris, Mario D Aceto
Pharmacology, Biochemistry, and Behavior|August 8, 2009
Removal of continuous nicotine infusion produces somatic but not behavioral signs of withdrawal in miceAndrew J Kwilasz, Louis S Harris, Robert E Vann
Journal of Medicinal Chemistry|July 22, 2005
Effect of a 6-cyano substituent in 14-oxygenated N-methylmorphinans on opioid receptor binding and antinociceptive potencyMariana Spetea, Elisabeth Greiner, Mario D Aceto, et al.
European Journal of Pharmacology|April 17, 2007
Pharmacological studies with a nonpeptidic, delta-opioid (-)-(1R,5R,9R)-5,9-dimethyl-2'-hydroxy-2-(6-hydroxyhexyl)-6,7-benzomorphan hydrochloride ((-)-NIH 11082)Mario D Aceto, Everette L May, Louis S Harris, et al.
Journal of Medicinal Chemistry|September 5, 2003
Synthesis and biological evaluation of 14-alkoxymorphinans. 20. 14-phenylpropoxymetopon: an extremely powerful analgesicJohannes Schütz, Mariana Spetea, Martin Koch, et al.
Experimental and Clinical Psychopharmacology|August 11, 2004
Discriminative stimulus, reinforcing, physical dependence, and antinociceptive effects of oxycodone in mice, rats, and rhesus monkeysPatrick M Beardsley, Mario D Aceto, Charles D Cook, et al.
European Journal of Pharmacology|April 27, 2007
NIH 11082 produces anti-depressant-like activity in the mouse tail-suspension test through a delta-opioid receptor mechanism of actionPattipati S Naidu, Aron H Lichtman, Carey C Archer, et al.
Bioorganic & Medicinal Chemistry|December 7, 2002
N-(trifluoromethyl)benzyl substituted N-normetazocines and N-norketobemidonesEverette L May, Andrew Coop, James H Woods, et al.
International Journal of Medicinal Chemistry|May 9, 2015
MDAN-21: A Bivalent Opioid Ligand Containing mu-Agonist and Delta-Antagonist Pharmacophores and Its Effects in Rhesus MonkeysMario D Aceto, Louis S Harris, S Stevens Negus, et al.
Pageof 2